Marblehead, MA, United States of America

Monica Wang


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Monica Wang: Pioneering Advances in Neurobiology

Introduction

Monica Wang, an innovative inventor based in Marblehead, MA, has made significant contributions to neurobiology through her research. With a focus on the applications of hedgehog proteins, she has filed two patents that showcase her expertise and dedication to understanding neuron behaviors.

Latest Patents

Her latest patents include "Vertebrate embryonic patterning-inducing proteins, compositions and uses related thereto" and "Method of treating dopaminergic and GABA-nergic disorders." These patents highlight the novel activities of hedgehog proteins, demonstrating their role not only in phenotype specification but also in promoting the survival of crucial neuronal types. Her work indicates that hedgehog proteins are trophic for dopaminergic neurons and play a vital role in the survival of midbrain GABA-immunoreactive neurons, indicating potential therapeutic applications.

Career Highlights

Monica Wang is currently employed at Curis, Inc., a company known for its innovative approaches in biotechnology. Her research efforts and the resulting patents reflect her commitment to advancing treatment options for neurologic disorders, making a notable impact in her field.

Collaborations

Throughout her career, Monica has collaborated with notable colleagues including Ningning Miao and Nagesh K Mahanthappa. These partnerships not only enhance her research capabilities but also foster a collaborative spirit aimed at addressing complex challenges within neurobiology.

Conclusion

Monica Wang's work exemplifies the intersection of innovation and medicine, particularly in the realm of neuronal health. Her patents and collaborations underscore her role as a leading inventor in the field, paving the way for more effective treatments for disorders affecting dopaminergic and GABAergic systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…